BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Z, Wen Y, Xuan C, Chen Q, Xiang Q, Wang J, Liu Y, Luo L, Zhao S, Deng Y, Zhao Z. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis. FEBS Open Bio 2020;10:674-88. [PMID: 32027093 DOI: 10.1002/2211-5463.12805] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kinget L, Roussel E, Lambrechts D, Boeckx B, Vanginderhuysen L, Albersen M, Rodríguez-Antona C, Graña-Castro O, Inglada-Pérez L, Verbiest A, Zucman-Rossi J, Couchy G, Caruso S, Laenen A, Baldewijns M, Beuselinck B. MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma. Cancers (Basel) 2021;13:1554. [PMID: 33800656 DOI: 10.3390/cancers13071554] [Reference Citation Analysis]
2 Samaržija I. Site-Specific and Common Prostate Cancer Metastasis Genes as Suggested by Meta-Analysis of Gene Expression Data. Life (Basel) 2021;11:636. [PMID: 34209195 DOI: 10.3390/life11070636] [Reference Citation Analysis]
3 Moussa Agha D, Rouas R, Najar M, Bouhtit F, Naamane N, Fayyad-Kazan H, Bron D, Meuleman N, Lewalle P, Merimi M. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. Int J Mol Sci 2020;21:E7065. [PMID: 32992819 DOI: 10.3390/ijms21197065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Nizioł M, Zińczuk J, Zaręba K, Guzińska-Ustymowicz K, Pryczynicz A. Immunohistochemical Analysis of the Expression of Adhesion Proteins: TNS1, TNS2 and TNS3 in Correlation with Clinicopathological Parameters in Gastric Cancer. Biomolecules 2021;11:640. [PMID: 33926026 DOI: 10.3390/biom11050640] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Liu Y, Zhao S, Wang J, Zhu Z, Luo L, Xiang Q, Zhou M, Ma Y, Wang Z, Zhao Z. MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13. Front Oncol 2021;11:754353. [PMID: 34722307 DOI: 10.3389/fonc.2021.754353] [Reference Citation Analysis]
6 Panigrahi AR, Srinivas L, Panda J. Exosomes: Insights and therapeutic applications in cancer. Transl Oncol 2022;21:101439. [PMID: 35551002 DOI: 10.1016/j.tranon.2022.101439] [Reference Citation Analysis]
7 Zhao Z, Zhao S, Luo L, Xiang Q, Zhu Z, Wang J, Liu Y, Luo J. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Br J Cancer 2021;124:982-94. [PMID: 33239676 DOI: 10.1038/s41416-020-01187-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhu Z, Luo L, Xiang Q, Wang J, Liu Y, Deng Y, Zhao Z. MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis. Cell Death Dis 2020;11:949. [PMID: 33144585 DOI: 10.1038/s41419-020-03138-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
9 Tang C, Cai Y, Jiang H, Lv Z, Yang C, Xu H, Li Z, Li Y. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis. Aging (Albany NY) 2020;12:25547-63. [PMID: 33231563 DOI: 10.18632/aging.104162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Yan W, Huang J, Zhang Q, Zhang J. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers. J Oncol 2021;2021:9924473. [PMID: 34306081 DOI: 10.1155/2021/9924473] [Reference Citation Analysis]
11 Skrzypek K, Nieszporek A, Badyra B, Lasota M, Majka M. Enhancement of myogenic differentiation and inhibition of rhabdomyosarcoma progression by miR-28-3p and miR-193a-5p regulated by SNAIL. Mol Ther Nucleic Acids 2021;24:888-904. [PMID: 34094709 DOI: 10.1016/j.omtn.2021.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang L, Gao J, Zhang Y, Kang S. Silencing miRNA-1297 suppresses the invasion and migration of prostate cancer cells via targeting modulation of PTEN and blocking of the AKT/ERK pathway. Exp Ther Med 2021;22:768. [PMID: 34055067 DOI: 10.3892/etm.2021.10200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Oh-Hohenhorst SJ, Lange T. Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment. Cancers (Basel) 2021;13:4492. [PMID: 34503302 DOI: 10.3390/cancers13174492] [Reference Citation Analysis]
14 Olivan M, Garcia M, Suárez L, Guiu M, Gros L, Méndez O, Rigau M, Reventós J, Segura MF, de Torres I, Planas J, de la Cruz X, Gomis RR, Morote J, Rodríguez-barrueco R, Santamaria A. Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples. Cancers 2021;13:6202. [DOI: 10.3390/cancers13246202] [Reference Citation Analysis]
15 Chen Y, Chen Z, Mo J, Pang M, Chen Z, Feng F, Xie P, Yang B. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. Technol Cancer Res Treat 2021;20:1533033821990064. [PMID: 33596783 DOI: 10.1177/1533033821990064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Guo Y, Cui X, Zhang Y, Ma X, Ren A, Huang H. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer. Cancer Biother Radiopharm 2020. [PMID: 32898433 DOI: 10.1089/cbr.2020.4144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lin Y, Miao Z, Zhang X, Wei X, Hou J, Huang Y, Shen B. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey. Front Genet 2020;11:596826. [PMID: 33519899 DOI: 10.3389/fgene.2020.596826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]